Ultragenyx Pharmaceutical Inc SETRUSUMAB Phase 2 Data Conference Call Transcript - Thomson StreetEvents

Ultragenyx Pharmaceutical Inc SETRUSUMAB Phase 2 Data Conference Call Transcript

Ultragenyx Pharmaceutical Inc SETRUSUMAB Phase 2 Data Conference Call Transcript - Thomson StreetEvents
Ultragenyx Pharmaceutical Inc SETRUSUMAB Phase 2 Data Conference Call Transcript
Published Jun 05, 2023
Published Jun 05, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of RARE.OQ conference call or presentation 5-Jun-23 9:00pm GMT

  
Report Type:

Transcript

Source:
Company:
Ultragenyx Pharmaceutical Inc
Ticker
RARE.OQ
Time
9:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Ultragenyx Pharmaceutical Inc Q2 2023 Earnings Call Summary – 2023-08-03 – US$ 54.00 – Edited Brief of RARE.OQ earnings conference call or presentation 3-Aug-23 9:00pm GMT

Ultragenyx Pharmaceutical Inc Q2 2023 Earnings Call Transcript – 2023-08-03 – US$ 54.00 – Edited Transcript of RARE.OQ earnings conference call or presentation 3-Aug-23 9:00pm GMT

Ultragenyx Pharmaceutical Inc at Goldman Sachs Healthcare Conference Summary – 2023-06-12 – US$ 54.00 – Edited Brief of RARE.OQ presentation 12-Jun-23 10:20pm GMT

Ultragenyx Pharmaceutical Inc at Goldman Sachs Healthcare Conference Transcript – 2023-06-12 – US$ 54.00 – Edited Transcript of RARE.OQ presentation 12-Jun-23 10:20pm GMT

Ultragenyx Pharmaceutical Inc SETRUSUMAB Phase 2 Data Conference Call Summary – 2023-06-05 – US$ 54.00 – Edited Brief of RARE.OQ conference call or presentation 5-Jun-23 9:00pm GMT

Ultragenyx Pharmaceutical Inc at Barclays Virtual Gene Editing & Therapy Summit Transcript – 2023-05-24 – US$ 54.00 – Edited Transcript of RARE.OQ presentation 24-May-23 12:50pm GMT

Ultragenyx Pharmaceutical Inc at Bank of America Global Healthcare Conference Transcript – 2023-05-10 – US$ 54.00 – Edited Transcript of RARE.OQ presentation 10-May-23 4:20pm GMT

Ultragenyx Pharmaceutical Inc Q1 2023 Earnings Call Transcript – 2023-05-04 – US$ 54.00 – Edited Transcript of RARE.OQ earnings conference call or presentation 4-May-23 9:00pm GMT

Ultragenyx Pharmaceutical Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) Transcript – 2023-04-03 – US$ 54.00 – Edited Transcript of RARE.OQ presentation 3-Apr-23 2:45pm GMT

Ultragenyx Pharmaceutical Inc at Cowen Health Care Conference- Orphan CNS Panel Discussion Transcript – 2023-03-07 – US$ 54.00 – Edited Transcript of RARE.OQ presentation 7-Mar-23 3:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Ultragenyx Pharmaceutical Inc SETRUSUMAB Phase 2 Data Conference Call Transcript" Jun 05, 2023. Alacra Store. May 04, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Ultragenyx-Pharmaceutical-Inc-SETRUSUMAB-Phase-2-Data-Conference-Call-T15624580>
  
APA:
Thomson StreetEvents. (2023). Ultragenyx Pharmaceutical Inc SETRUSUMAB Phase 2 Data Conference Call Transcript Jun 05, 2023. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Ultragenyx-Pharmaceutical-Inc-SETRUSUMAB-Phase-2-Data-Conference-Call-T15624580>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.